Novartis Ag (NVSEF) Goodwill & Intangibles (2009 - 2026)

Novartis Ag has disclosed Goodwill & Intangibles across 13 years of filings, most recently posting $12.0 billion for Q1 2026.

• Goodwill & Intangibles for Q1 2026 came in at $12.0 billion, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $12.0 billion (changed N/A YoY), and the FY2025 annual result was $55.0 billion, up 6.4% from the prior year.
• Goodwill & Intangibles came in at $12.0 billion for Q1 2026 at Novartis Ag, down from $55.0 billion in the prior quarter.
• In the past five years, Goodwill & Intangibles ranged from a high of $81.7 billion in Q4 2023 to a low of $162.0 million in Q3 2022.
• The 5-year median for Goodwill & Intangibles is $39.2 billion (2022), against an average of $32.9 billion.
• Across the five-year window, Goodwill & Intangibles tumbled 62.76% in 2022 and jumped 4795.74% in 2023, its largest moves.
• Novartis Ag's Goodwill & Intangibles stood at $26.7 billion in 2022, then soared by 206.21% to $81.7 billion in 2023, then plunged by 36.72% to $51.7 billion in 2024, then advanced by 6.4% to $55.0 billion in 2025, then tumbled by 78.17% to $12.0 billion in 2026.
• The last three Goodwill & Intangibles figures came in at $12.0 billion (Q1 2026), $55.0 billion (Q4 2025), and $54.8 billion (Q2 2025), per Business Quant data.